Physician profile
Elissa Lebow
NPI 1841479540
$3,677.47
in general payments reported to CMS, 2019-2025
10 companies · $713 in 2025
The $713 reported for 2025 was more than what 86% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $380 · 2022: $1,016 · 2023: $668 · 2024: $901 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,281.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,234.87 | 2021-2024 | Corevalve Evolut R |
| Atricure, INC. | $811.18 | 2021-2024 | |
| Abiomed | $761.92 | 2022-2025 | Impella |
| Edwards Lifesciences Corporation | $458.87 | 2022-2025 | Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve, Konect Resilia |
| Abbott Laboratories | $151.04 | 2025 | Navitor |
| Imperative Care, INC | $129.18 | 2025 | Prodigy Catheter, Symphony Catheter, Hotshot Controller |
| Ethicon US, LLC | $53.95 | 2022-2023 | Evarrest |
| Baxter Healthcare | $46.54 | 2022 | |
| Angiodynamics, INC. | $15.78 | 2023 | Angiovac |
| Getinge USA Sales, LLC | $14.14 | 2024 | Vasoview Hemopro 2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elissa Lebow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.